 |
市場調查報告書
商品編碼
1689718
超低溫冷凍機：市場佔有率分析、產業趨勢與統計、成長預測（2025-2030）Ultra-Low Temperature Freezers - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) |
||||||
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計超低溫 (ULT) 冷凍機市場在預測期內的複合年成長率將達到 6.52%。
超低溫冰箱在大量 COVID-19 疫苗的儲存和分發中發揮了關鍵作用，這些疫苗需要超低溫條件，因此 COVID-19 對市場成長的影響很大。例如，根據2022年2月發表在《人類疫苗與治療學雜誌》上的一篇論文，食品藥物管理局（FDA）的指南規定，輝瑞-BioNTech的mRNA COVID-19疫苗BNT162b2在接受後應在-80°C至-60°C的超低溫冷凍庫中保存長達六個月。因此，建議將 COVID-19 疫苗儲存在超低溫冷凍庫中的指南對市場成長產生了重大影響。因此，COVID-19 在疫情初期就影響了超低溫冰箱的使用。不過，疫情目前已經消退，超低溫冰箱的採用率已恢復到疫情前的水準。因此，預計研究市場在研究預測期內將經歷疫情前的成長水準。
推動市場成長的因素包括生物庫、藥物發現和生命科學研究中的應用不斷增加，以及超低溫冰箱的技術進步。
生物庫中擴大使用超低溫冰箱來儲存生物樣本是推動市場成長的一個主要因素。例如，根據《快速透明出版雜誌》2022 年 9 月發表的報導，烏干達馬凱雷雷大學的 H3Africa 烏干達綜合生物庫 (IBRH3AU) 是東非首批擁有 20 台超低溫 (ULT)冷凍庫櫃的冷凍庫農場的生物庫之一。此生物庫的超低溫冰箱可將樣本保存在-70°C至-80°C之間，容量為50,400個2毫升管瓶，確保生物樣本得到妥善保存。因此，生物庫中超低溫冷凍機的採用有望促進市場成長。
此外，2021年6月，賽默飛世爾科技推出了賽默飛世爾科技TSX系列超低溫冰箱。這些冷凍庫的另一個好處是，它為研究、製藥、臨床、生物檢體資料庫和工業實驗室提供了安全保障，以環境永續的方式保護疫苗、細胞培養基、生技藥品和試劑等材料。同樣，2022年10月，賽默飛世爾科技也宣布推出賽默飛世爾科技TDE系列-80°C立式冷凍櫃。因此，主要市場參與企業推出的各種技術先進的超低溫冷凍機也有望透過增加其使用量來推動市場發展。
因此，由於上述因素，例如生物庫中超低溫冰箱的採用率不斷提高以及主要市場參與企業推出的產品不斷增加，預計市場在預測期內將呈現成長。然而，超低溫冷凍機的高成本以及超低溫冷凍機的嚴格監管問題可能會阻礙市場成長。
超低溫冷凍機的市場趨勢
預計在預測期內，立式超低溫冷凍機將佔據相當大的市場佔有率。
直立式超低溫冰箱具有開啟後快速冷卻、方便取用和可單獨客製化隔間以供常規使用等特點。然而，臥式超低溫冷凍機可以安全地長期儲存不常用的物品，讓您可以將臥式超低溫冷凍機用於特定目的。直立式超低溫冰箱（ULT 冰箱）的溫度範圍通常為 -40°C 至 -86°C，用於儲存藥品、酵素、化學物質、病毒、細菌、細胞製劑、組織樣本等。立式 ULT 冰箱的這些優勢預計將在不久的將來推動此類冷凍庫的普及。
此外，生物庫的增加和與直立式 ULT冷凍相關的技術進步預計將促進該領域的成長。例如，2023 年 3 月，南非推出了一個中央生物庫網路—南非生物多樣性生物庫 (BBSA)。該網路旨在將先前分佈在南非各地的 7 個機構和 22 個不同的生物庫聯合起來，以儲存和管理生物多樣性樣本。同樣，沙烏地阿拉伯於2022年12月推出了國家生物庫，以加強其公共衛生系統。這有望加強國家衛生安全，提高感染疾病和非感染疾病控制計畫和控制的有效性，並有效促進沙烏地阿拉伯的研究、開發和創新議程的推進。
此外，藥物和疫苗研發活動的激增也推動了該領域的成長。例如，根據 ClinicalTrials.Gov 於 2023 年 5 月 30 日更新的資料，估計有 1,946 項針對該疫苗的活躍臨床試驗。預計未來幾年將推出幾種處於臨床試驗階段的疫苗，這些疫苗可能需要超低溫條件來儲存和運輸成分。
因此，所有上述因素，例如生物庫的增加、垂直超低溫冷凍機的技術進步以及藥物臨床測試的增加，預計都將增加對立式超低溫冷凍機的需求，從而促進該領域的成長。
預計北美將在預測期內佔據主要市場佔有率
由於生物庫、製藥公司和生物技術公司的存在，北美預計將佔據超低溫冷凍機市場的很大佔有率。
預計活性化的研發活動和政府對細胞治療方法和疫苗的支持將推動市場成長。例如，2023 年 3 月，Jubilant HollisterStier 從加拿大政府獲得 2,380 萬美元的策略創新資金，用於提高其包括 mRNA 在內的各種疫苗的生產能力和年度填充能力。因此，隨著該國疫苗研發的活躍，以及疫苗研發早期階段通常需要超低溫，預計對超低溫冰箱的需求將會增加。
此外，技術先進的超低溫冷凍機的高採用率和主要市場參與企業推出的產品預計將推動整個區域市場的成長。例如，2022 年 10 月，賽默飛世爾科技宣布將把 ThermoScientific TDE 系列 -80°C 直立式冷凍機添加到其超低溫 (ULT) 綠線中。
預計在預測期內，市場參與企業在 ULTF 供應方面的合作將不斷加強，從而推動市場向前發展。例如，2021 年 2 月，北美 PHC 公司 (PHCNA) 和 Middleby 公司旗下的 Follett Products, LLC (Follett) 宣佈建立夥伴關係，向 Follett 的醫療保健客戶分銷 PHCbiline 醫藥級冰箱和生物醫學冷凍庫（超低溫 (ULT)冷凍庫）。
因此，所有上述因素，例如疫苗研發活動的活性化、市場參與企業向新興國家擴張等，預計都將增加對超低溫冷凍庫的需求，從而在預測期內推動市場成長。
超低溫冷凍機產業概況
市場競爭激烈，多家公司參與競爭。市場的主要企業包括賽默飛世爾科技公司、PHC Holdings Corporation、海爾智慧家居（海爾生物醫療）、Eppendorf SE 和 BioLife Solutions, Inc.
其他福利
- Excel 格式的市場預測 (ME) 表
- 3個月的分析師支持
目錄
第1章 引言
- 研究假設和市場定義
- 研究範圍
第2章調查方法
第3章執行摘要
第4章 市場動態
- 市場概覽
- 市場促進因素
- 在生物庫、藥物研發和生命科學研究的應用日益增多
- 超低溫冷凍機的技術進步
- 市場限制
- 超低溫冷凍機高成本
- 超低溫冷凍機的嚴格監管問題
- 波特五力分析
- 新進入者的威脅
- 買家/消費者的議價能力
- 供應商的議價能力
- 替代品的威脅
- 競爭對手之間的競爭強度
第5章市場區隔
- 依產品類型
- 直立式超低溫冰箱
- 臥式超低溫冰箱
- 按最終用戶
- 生物樣本庫
- 製藥和生物技術公司
- 學術和研究機構
- 其他
- 按地區
- 北美洲
- 美國
- 加拿大
- 墨西哥
- 歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 其他歐洲國家
- 亞太地區
- 中國
- 日本
- 印度
- 澳洲
- 韓國
- 其他亞太地區
- 中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區
- 南美洲
- 巴西
- 阿根廷
- 南美洲其他地區
- 北美洲
第6章競爭格局
- 公司簡介
- Thermo Fisher Scientific Inc.
- PHC Holdings Corporation
- Haier Smart Home Co., Ltd（Haier Biomedical）
- Arctiko
- Helmer Scientific Inc
- Eppendorf SE
- Abzil Telstar SL
- Labcold Ltd.
- Bionics Scientific Technologies（P）Ltd
- BioLife Solutions, Inc.
第7章 市場機會與未來趨勢
The Ultra-Low Temperature Freezers Market is expected to register a CAGR of 6.52% during the forecast period.
The impact of COVID-19 on the market's growth was substantial as ultra-low temperature freezers played a crucial role in the storage and distribution of large amounts of COVID-19 vaccines that required ultra-cold conditions. For instance, according to the article published in the Journal of Human Vaccines and Therapeutics in February 2022, according to the Food and Drug Administration (FDA) guidelines, the Pfizer-BioNTech mRNA COVID-19 vaccine BNT162b2 required to be stored in ultra-low temperature-freezers -80°C to -60°C for up to six months after receiving. Thus, the guidelines suggesting the storage of COVID-19 vaccines in ultra-low temperature freezers significantly impacted the market growth. Thus, COVID-19 has impacted the usage of ultra-low temperature freezers during the initial pandemic. However, as the pandemic has currently subsided, the adoption of ultra-low temperature freezers is taking place at pre-pandemic levels. Thus, the studied market is expected to have pre-pandemic levels of growth during the forecast period of the study.
Factors that are responsible for the market growth includes rising applications in bio-banks, drug discovery and life-sciences research, and technological advancement in ultra-low temperature freezers.
The increased usage of ultra-low temperature freezers to store biological samples in bio-banks is a major factor propelling the market's growth. For instance, according to an article published by the Journal of Rapid and Transparent Publishing in September 2022, the Integrated Biorepository of H3Africa Uganda (IBRH3AU) at Makerere University in Uganda is one of the first biobanks of its kind in Eastern Africa which has freezer firm that is equipped with 20 ultra-low temperature (ULT) freezers. The source also stated that the biobank's ultra-low temperature freezers were capable of storage from -70°C to -80°C and had a capacity of 50,400 2 ml vials each which allowed them to store biological samples properly. Thus, the adoption of ultra-low temperature freezers in biobanks is expected to increase market growth.
Additionally, in June 2021, ThermoFisher Scientific Inc. launched the ThermoScientific TSX Series Ultra-Low Temperature (ULT) Freezers. These freezers included additional functionality to provide research, pharmaceutical manufacturing, clinical, biorepository, and industrial laboratories with safeguards to deliver environmentally sustainable protection of materials, such as vaccines, cell culture media, biologics, and reagents. Similarly, In October 2022, ThermoFisher Scientific Inc. also announced the launch of Thermo Scientific TDE Series -80°C Chest Freeze in the market. Thus, the launch of various technologically advanced ultra-low temperature freezers by key market players is also expected to boost the market, as it would increase their usage.
Thus, owing to the abovementioned factors such as the increasing adoption of ultra-low temperature freezers in biobanks, and the rising product launches by major market players, the market is expected to show growth over the forecast period. However, high costs associated with ultra-low temperature freezers and stringent regulatory issues regarding ultra-low temperature freezers may hinder the growth of the market.
Ultra Low Temperature Freezer Market Trends
Upright ULT Freezers Segment is Expected to Hold a Significant Market Share Over the Forecast Period
The upright ULT freezer enables quick cooling after opening, simple access, and individually customizable inner compartments for regular usage. However, less used items can be stored in a chest ULT freezer safely for an extended period of time that, allows the usage of the chest ULT for specific purposes. Upright ultra-low temperature freezers (ULT freezers) typically have a temperature range of -40°C to -86°C and are used to store drugs, enzymes, chemicals, viruses, bacteria, cell preparations, and tissue samples. Such advantages offered by upright ULTs are anticipated to boost the adoption of these freezers in the near future.
Additionally, an increasing number of biobanks and technological advancements related to upright ULT freezers are expected to enhance segment growth. For instance, in March 2023, South Africa launched a central biobank network, Biodiversity Biobanks South Africa (BBSA). This network aims to bring together 7 institutions and 22 different biobanks previously scattered across South Africa to conserve and manage biodiversity samples. Similarly, in December 2022, Saudi Arabia launched National Biobank to enhance the public health system. This is expected to strengthen national health security, increase the effectiveness of control programs and control of communicable and non-communicable diseases, as well as effectively contribute to the promotion of Saudi Arabia's research, development, and innovation agenda.
Moreover, the segment's growth is driven by a surge in research and development activities for pharmaceutical drugs and vaccines. For instance, according to the data updated by ClinicalTrials.Gov on 30th May 2023, there were an estimated 1,946 active clinical trials for vaccines. Several vaccines under clinical trial are expected to be launched over the coming years that may require ultra-cold conditions for storage and transportation of raw materials.
Thus, all the above factors such as the increasing number of biobanks, technological advancements in upright ultra-low temperature freezers, and the rising clinical trials for drugs are expected to increase demand for upright ULT freezers, thereby boosting the segment's growth.
North America is Expected to Hold a Significant Share in the Market Over the Forecast Period
North America is expected to hold a significant market share in the ultra-low temperature freezers market due to the presence of several biobanks, pharmaceuticals, and biotechnology companies within the region.
The growing research and development activities on cell-based therapies and vaccines and government support are expected to boost the market growth. For instance, in March 2023, Jubilant HollisterStierreceived a USD 23.8 million Strategic Innovation Fund from the government of Canada's commitment to boost its capacity for a variety of vaccines, including mRNA, as well as its yearly fill and finish capacity. Thus, with significant vaccines development activities in the country, the demand for ultra-low temperature freezers is expected to increase as ultra-low temperatures are often required in the initial stages of vaccine development.
Furthermore, the high adoption of technologically advanced ultra-low temperature freezers and product launches by major market players are expected to propel the growth of the overall regional market. For instance, in October 2022, ThermoFisher Scientific announced the addition of the ThermoScientific TDE Series -80°C Chest Freezer to their ultra-low temperature (ULT) green line.
The rising collaboration between the market players for the supply of ULTF is expected to put forward the market over the forecast period. For instance, in February 2021, PHC Corporation of North America (PHCNA) and Follett Products, LLC (Follett), a division of The MiddlebyCorporation, announced the formation of a partnership to market and sell the PHCbiline of ultra-low temperature (ULT) freezers pharmaceutical grade refrigerators, and biomedical freezers to Follett's healthcare customers.
Thus, all the factors mentioned above such as the increasing research and development activities for vaccine developments, and the rising developments by market players are expected to increase demand for ultra-low temperature freezers and boost market growth over the forecast period.
Ultra Low Temperature Freezer Industry Overview
The market studied is moderately competitive, and several companies are operating in this market. Some of the major players operating in the market include Thermo Fisher Scientific, Inc., PHC Holdings Corporation, Haier Smart Home Co., Ltd (Haier Biomedical), Eppendorf SE, and BioLife Solutions, Inc., among others.
Additional Benefits:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
TABLE OF CONTENTS
1 INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2 RESEARCH METHODOLOGY
3 EXECUTIVE SUMMARY
4 MARKET DYNAMICS
- 4.1 Market Overview
- 4.2 Market Drivers
- 4.2.1 Rising Applications in Bio-Banks, Drug Discovery and Life-Sciences Research
- 4.2.2 Technological Advancement in Ultra-Low Temperature Freezers
- 4.3 Market Restraints
- 4.3.1 High Costs Associated with Ultra-Low Temperature Freezers
- 4.3.2 Stringent Regulatory Issues Regarding Ultra-Low Temperature Freezers
- 4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION (Market Size by Value - USD million)
- 5.1 By Product Type
- 5.1.1 Upright ULT freezers
- 5.1.2 Chest ULT freezers
- 5.2 By End User
- 5.2.1 Bio-Banks
- 5.2.2 Pharmaceutical and Biotechnology Companies
- 5.2.3 Academic and Research Laboratories
- 5.2.4 Others
- 5.3 Geography
- 5.3.1 North America
- 5.3.1.1 United States
- 5.3.1.2 Canada
- 5.3.1.3 Mexico
- 5.3.2 Europe
- 5.3.2.1 Germany
- 5.3.2.2 United Kingdom
- 5.3.2.3 France
- 5.3.2.4 Italy
- 5.3.2.5 Spain
- 5.3.2.6 Rest of Europe
- 5.3.3 Asia-Pacific
- 5.3.3.1 China
- 5.3.3.2 Japan
- 5.3.3.3 India
- 5.3.3.4 Australia
- 5.3.3.5 South Korea
- 5.3.3.6 Rest of Asia-Pacific
- 5.3.4 Middle East and Africa
- 5.3.4.1 GCC
- 5.3.4.2 South Africa
- 5.3.4.3 Rest of Middle East and Africa
- 5.3.5 South America
- 5.3.5.1 Brazil
- 5.3.5.2 Argentina
- 5.3.5.3 Rest of South America
- 5.3.1 North America
6 COMPETITIVE LANDSCAPE
- 6.1 Company Profiles
- 6.1.1 Thermo Fisher Scientific Inc.
- 6.1.2 PHC Holdings Corporation
- 6.1.3 Haier Smart Home Co., Ltd (Haier Biomedical)
- 6.1.4 Arctiko
- 6.1.5 Helmer Scientific Inc
- 6.1.6 Eppendorf SE
- 6.1.7 Abzil Telstar S.L
- 6.1.8 Labcold Ltd.
- 6.1.9 Bionics Scientific Technologies (P) Ltd
- 6.1.10 BioLife Solutions, Inc.
